Preview (2 of 1 Pages)100%Purchase to unlockPage 1Loading page ...EthicsCase10-12onpage553-MayerBiotechnical,Inc-Researchanddevelopment®LO8MayerBiotechnical,Inc.,develops,manufactures,andsellspharmaceuticals.Significantresearchanddevelopment(R&D)expendituresaremadeforthedevelopmentofnewdrugsandtheimprovementofexistingdrugs.During2011,$220millionwasspentonR&D.Ofthisamount,$30millionwasspentonthepurchaseofequipmenttobeusedinaresearchprojectinvolvingthedevelopmentofanewantibiotic.Thecontroller,AliceCooper,isconsideringcapitalizingtheequipmentanddepreciatingitoverthefive-yearusefullifeoftheequipmentat$6millionperyear,eventhoughtheequipmentlikelywillbeusedononlyoneproject.ThecompanypresidenthasaskedAlicetomakeeveryefforttoincrease2011earningsbecausein2012thecompanywillbeseekingsignificantnewfinancingfrombothdebtandequitysources.“Iguesswemightusetheequipmentinotherprojectslater,”Alicewonderedtoherself.Required:1.Assumingthattheequipmentwaspurchasedatthebeginningof2011,byhowmuchwouldAlice’streatmentoftheequipmentincreasebeforetaxearningsasopposedtoexpensingtheequipmentcost?2.DiscusstheethicaldilemmaAlicefacesindeterminingthetreatmentofthe$30millionequipmentpurchase.I~StudyXYPage 2Report